Healthcare challenges stemming from disparities in access and quality can be tackled through biotechnology. Genetic sequencing is pivotal in this effort, offering personalized treatment options and early disease identification.

Miroculus develops innovative solutions for early disease detection by automating sample preparation for next-generation-sequencing. This approach has the potential to improve patient outcomes by enabling more timely interventions.

HQ
San Francisco, USA